Emory University Hospital

Type: Teaching hospital
Where: Atlanta, GA
Medicare CCN: 110010
Received: $53,386,919 in 3,830 records, 2020 ($7,862,363 general, $45,524,556 research)
Source: CMS Open Payments search ↗

By year

Program year	Kind	Records	Amount
2020	General payment	380	$7,862,363
2020	Research payment	3,450	$45,524,556

By company

Company	Records	Amount	Years
PFIZER INC.	146	$7,504,523	2020
Gilead Sciences, Inc.	101	$3,636,930	2020
SEAGEN INC.	52	$3,291,925	2020
Novartis Pharmaceuticals Corporation	24	$2,637,449	2020
Takeda Pharmaceuticals U.S.A., Inc.	234	$2,630,538	2020
Celgene Corporation	19	$2,375,253	2020
Merck Sharp & Dohme LLC	285	$2,299,950	2020
E.R. Squibb & Sons, L.L.C.	56	$1,928,577	2020
Amgen Inc.	53	$1,854,095	2020
Genentech, Inc.	67	$1,492,997	2020
AstraZeneca Pharmaceuticals LP	38	$1,365,902	2020
Biogen, Inc.	13	$1,361,360	2020
Ipsen Biopharmaceuticals, Inc	11	$1,119,752	2020
BioMarin Pharmaceutical Inc.	55	$969,485	2020
Regeneron Pharmaceuticals, Inc.	68	$949,376	2020
Edwards Lifesciences Corporation	83	$906,567	2020
Novo Nordisk Inc	25	$869,147	2020
Janssen Research & Development, LLC	111	$819,351	2020
Eli Lilly and Company	21	$754,151	2020
ABBVIE INC.	104	$722,034	2020
Medtronic Vascular, Inc.	68	$571,096	2020
Medtronic USA, Inc.	56	$549,008	2020
Boston Scientific Corporation	132	$539,712	2020
Allergan, Inc.	74	$526,354	2020
Abbott Laboratories	81	$463,686	2020
SANOFI-AVENTIS U.S. LLC	2	$384,517	2020
Siemens Medical Solutions USA, Inc.	50	$359,371	2020
Zimmer Biomet Holdings, Inc.	23	$357,968	2020
Stryker Corporation	7	$355,373	2020
Medical Device Business Services, Inc.	36	$325,108	2020
Exelixis Inc.	5	$317,697	2020
VERTEX PHARMACEUTICALS INCORPORATED	5	$296,549	2020
Soleno Therapeutics, Inc.	2	$282,397	2020
Alkermes, Inc.	44	$255,594	2020
Eisai Inc.	120	$252,421	2020
Kadmon Corporation LLC	3	$228,971	2020
Acerta Pharma LLC	1	$214,935	2020
CSL Behring	39	$214,092	2020
Incyte Corporation	164	$212,166	2020
Neuronetics, Inc.	4	$203,442	2020
GENZYME CORPORATION	24	$191,117	2020
AstraZeneca UK Limited	13	$183,535	2020
KARL STORZ Endoscopy-America	90	$182,366	2020
Cerus Corporation	10	$178,693	2020
Varian Medical Systems, Inc.	8	$165,796	2020
SANOFI PASTEUR INC.	8	$165,220	2020
Sirtex Medical Inc	3	$157,000	2020
Blue Earth Diagnostics	7	$155,454	2020
United Therapeutics Corporation	37	$149,017	2020
Amicus Therapeutics, Inc.	13	$143,347	2020

By nature of payment

Nature	Records	Amount
Research payment	3,450	$45,524,556
Grant	64	$5,317,863
Royalty or License	106	$1,670,361
Space rental or facility fees (teaching hospital only)	55	$254,865
Education	97	$242,941
Consulting Fee	19	$198,105
Compensation for services other than consulting, including serving as faculty or as a speaker at a v	11	$83,126
Gift	16	$62,754
Charitable Contribution	8	$29,375
Food and Beverage	3	$2,873
Travel and Lodging	1	$96

Records

Date	Company	Amount	Nature	Form	Product	Study	Year
2020-12-31	Allergan, Inc.	$107,000	Research payment	In-kind items and services		A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o	2020
2020-12-31	KARL STORZ Endoscopy-America	$20,043	Education	In-kind items and services	VISITOR1 CART PACKAGED, W/ HEAD, SW, 2.0 Device, OR1		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$16,883	Research payment	In-kind items and services	TAGRISSO Drug, Oncology	A Phase III, randomized, double-blind, placebo-controlled, multicenter, international study of osimertinib as maintenanc	2020
2020-12-31	KARL STORZ Endoscopy-America	$16,246	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Stryker Corporation	$14,864	Gift	In-kind items and services	PRIME ELECTRIC W/ ZOOM Device, PATIENT HANDLING - PH		2020
2020-12-31	SANOFI PASTEUR INC.	$13,026	Research payment	Cash or cash equivalent	FLUZONE HIGH-DOSE Biological, Vaccines	Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Childr	2020
2020-12-31	KARL STORZ Endoscopy-America	$10,341	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$10,341	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	Allergan, Inc.	$9,737	Research payment	In-kind items and services		The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension	2020
2020-12-31	CSL Behring	$9,088	Research payment	Cash or cash equivalent	Zemaira Biological, Pulmonary/Respiratory Diseases	A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 - Antitrypsin (AAT) Combined With	2020
2020-12-31	Stryker Corporation	$8,877	Gift	Cash or cash equivalent	NONE Device, NONE		2020
2020-12-31	KARL STORZ Endoscopy-America	$7,346	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca UK Limited	$7,186	Research payment	In-kind items and services		The purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre R	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$6,429	Research payment	Cash or cash equivalent		Emory2018MRIPR780Sharma	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$6,188	Research payment	Cash or cash equivalent		Emory2018MRIPR992BReiter	2020
2020-12-31	Allergan, Inc.	$6,093	Research payment	In-kind items and services		A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamoreli	2020
2020-12-31	KARL STORZ Endoscopy-America	$5,971	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$5,836	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$5,817	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$5,584	Research payment	In-kind items and services		A Multi arm Phase Ib Open Label, Multicentre Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary An	2020
2020-12-31	PFIZER INC.	$5,360	Research payment	Cash or cash equivalent	LORBRENA Drug, ONCOLOGY	PHASE 1 STUDY OF LORLATINIB PF06463922 AN ORAL SMALL MOLECULE INHIBITOR OF ALK ROS1 FOR PATIENTS WITH ALKDRIVEN RELAPSED	2020
2020-12-31	KARL STORZ Endoscopy-America	$4,814	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$4,528	Research payment	In-kind items and services		Multiarm Open label multicenter phase 1b 2 study to evaluate novel combination therapies in subjects with previously tre	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$4,401	Research payment	Cash or cash equivalent			2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$4,125	Research payment	Cash or cash equivalent		Emory2017MRIPR814Shim	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$4,125	Research payment	Cash or cash equivalent		Emory2019MRIPR928Oshinski	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$3,750	Research payment	Cash or cash equivalent		Emory2016MRIPR544Saindane	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$3,750	Research payment	Cash or cash equivalent		Emory2017MRIPR816AOshinski	2020
2020-12-31	VASCULAR SOLUTIONS, INC.	$3,612	Research payment	In-kind items and services	Interventional Products Device, Interventional Access	CTO-PCI	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$3,549	Research payment	Cash or cash equivalent		Emory2019MRIPR1024Oshinski	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$3,286	Research payment	Cash or cash equivalent		EmoryOshinskiCardioClinicalMR	2020
2020-12-31	KARL STORZ Endoscopy-America	$2,815	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,721	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,721	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,721	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,720	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$2,647	Research payment	Cash or cash equivalent		Emory2016MRIPR780CSharma	2020
2020-12-31	KARL STORZ Endoscopy-America	$2,583	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$2,520	Research payment	In-kind items and services		A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclon	2020
2020-12-31	KARL STORZ Endoscopy-America	$2,492	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,492	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$2,197	Research payment	Cash or cash equivalent	MAGNETOM Aera Device, MR - MRI	Emory2016MRIPR921Sharma	2020
2020-12-31	KARL STORZ Endoscopy-America	$2,196	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$2,196	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$2,167	Research payment	Cash or cash equivalent		EmoryDeCeccoAICombinationCT	2020
2020-12-31	Stryker Corporation	$2,086	Gift	Cash or cash equivalent	NONE Device, NONE		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$2,063	Research payment	Cash or cash equivalent		Emory2018MRIPR814Shim	2020
2020-12-31	KARL STORZ Endoscopy-America	$1,870	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$1,746	Research payment	Cash or cash equivalent		Emory2018MRIPR1032Oshinski	2020
2020-12-31	KARL STORZ Endoscopy-America	$1,727	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Allergan, Inc.	$1,726	Research payment	In-kind items and services		An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma	2020
2020-12-31	KARL STORZ Endoscopy-America	$1,721	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$1,584	Research payment	Cash or cash equivalent		Analysis of Mitral Valve	2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$1,581	Research payment	In-kind items and services	FASENRA Drug, Respiratory	PONENTE A Multicenter Open-label Phase 3b Efficacy and Safety Study of Benralizumab 30 mg Administered Subcutaneously to	2020
2020-12-31	KARL STORZ Endoscopy-America	$1,485	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$1,485	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$1,258	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$1,065	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$1,031	Research payment	Cash or cash equivalent		Emory2019MRIPR1032Oshinski555483	2020
2020-12-31	KARL STORZ Endoscopy-America	$1,028	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	VASCULAR SOLUTIONS, INC.	$1,014	Research payment	In-kind items and services	Interventional Products Device, Interventional Access	CTO-PCI	2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$996	Research payment	In-kind items and services	FASENRA Drug, Respiratory	A Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study Of Benralizuma	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$986	Research payment	Cash or cash equivalent		EmoryTreadway2016SpectroscopyMR	2020
2020-12-31	KARL STORZ Endoscopy-America	$907	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$844	Research payment	Cash or cash equivalent		Emory2016MRIPR838CSharma	2020
2020-12-31	KARL STORZ Endoscopy-America	$839	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$796	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$796	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$796	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$794	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	VASCULAR SOLUTIONS, INC.	$770	Research payment	In-kind items and services	Interventional Products Device, Interventional Access	CTO-PCI	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$756	Research payment	Cash or cash equivalent		Emory2020MRIPR780Sharma	2020
2020-12-31	AstraZeneca UK Limited	$753	Research payment	In-kind items and services	IMFINZI Drug, Oncology	A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresect	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$750	Research payment	Cash or cash equivalent		Emory2019MRIPR758Oshinski	2020
2020-12-31	AstraZeneca UK Limited	$706	Research payment	In-kind items and services	TAGRISSO Drug, Oncology	AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non small Cell Lung Cancer	2020
2020-12-31	KARL STORZ Endoscopy-America	$679	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$679	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$679	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$679	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$649	Research payment	Cash or cash equivalent		Emory2020MRIPR785Oshinski	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$645	Research payment	Cash or cash equivalent		Emory2018MRIPR785AOshinski	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$635	Research payment	Cash or cash equivalent		Emory2018MRIPR785Oshinski	2020
2020-12-31	Total Joint Orthopedics, Inc.	$612	Royalty or License	Cash or cash equivalent			2020
2020-12-31	KARL STORZ Endoscopy-America	$589	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$589	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$589	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$589	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$563	Research payment	Cash or cash equivalent		Emory2018MRIPR919Reiter	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$536	Research payment	Cash or cash equivalent		Emory2017MRIPR838ESharma	2020
2020-12-31	KARL STORZ Endoscopy-America	$493	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$480	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$421	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$414	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	KARL STORZ Endoscopy-America	$414	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$403	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$400	Research payment	Cash or cash equivalent		Emory2020MRIPR105810841315Allen	2020
2020-12-31	KARL STORZ Endoscopy-America	$381	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$381	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$363	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$363	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$350	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$317	Research payment	Cash or cash equivalent		Emory2019MRIPR1414De Cecco197543	2020
2020-12-31	KARL STORZ Endoscopy-America	$303	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$303	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$303	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$297	Education	In-kind items and services	TRAINER F/SIMULATED LAPAROSCOPIC Device, LAPAROSCOPY		2020
2020-12-31	KARL STORZ Endoscopy-America	$286	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$282	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$260	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$256	Research payment	In-kind items and services	IMFINZI Drug, Oncology	Phase III Open Label Study of MEDI 4736 With or Without Tremelimumab Versus Standard of Care SOC in Recurrent Metastatic	2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$240	Research payment	In-kind items and services		A Phase 1b/2, Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of Oleclumab (MEDI9447) with or with	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$201	Research payment	Cash or cash equivalent		Emory2020IPR8381041Sharma	2020
2020-12-31	Siemens Medical Solutions USA, Inc.	$195	Research payment	Cash or cash equivalent		Emory2018MRIPR529Dilks	2020
2020-12-31	AstraZeneca UK Limited	$185	Research payment	In-kind items and services		A Platform Protocol for the Treatment of Relapsed /Refractory Aggressive Non-Hodgkin's Lymphoma	2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$175	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$166	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$166	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$165	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$136	Research payment	In-kind items and services		Study of MEDI4736 Durvalumab With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer	2020
2020-12-31	KARL STORZ Endoscopy-America	$136	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$135	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$129	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$106	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$103	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	KARL STORZ Endoscopy-America	$99	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Masimo Corporation	$98	Education	In-kind items and services	SET and rainbow SET Device, Devices		2020
2020-12-31	Zimmer Biomet Holdings, Inc.	$85	Gift	In-kind items and services	Zimmer Biomet Instruments and Implants Device, General		2020
2020-12-31	Alkermes, Inc.	$85	Research payment	In-kind items and services	OLANZAPINE Drug, CNS	A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Sc	2020
2020-12-31	KARL STORZ Endoscopy-America	$56	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	AstraZeneca Pharmaceuticals LP	$50	Research payment	In-kind items and services	FARXIGA Drug, Cardiovascular and Metabolism	Forxiga HF-D1699C00001 HF rEF Outcome study	2020
2020-12-31	KARL STORZ Endoscopy-America	$44	Education	In-kind items and services	26 inch LED MONITOR Device, VIDEOIMAGING		2020
2020-12-31	Abbott Laboratories	$30	Research payment	In-kind items and services	HeartMate 3 Device, Cardiac Arrhythmias and Heart Failure	Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternoto	2020
2020-12-30	ABBVIE INC.	$31,795	Research payment	Cash or cash equivalent	VENCLEXTA Drug, ONCOLOGY	M15-538	2020
2020-12-30	ABBVIE INC.	$16,478	Research payment	Cash or cash equivalent	VENCLEXTA Drug, ONCOLOGY	M15-654	2020
2020-12-30	ABBVIE INC.	$1,458	Research payment	Cash or cash equivalent		M15-566	2020
2020-12-30	ABBVIE INC.	$925	Research payment	Cash or cash equivalent	VENCLEXTA Drug, ONCOLOGY	M13-833	2020
2020-12-30	Merck Sharp & Dohme LLC	$236	Research payment	Cash or cash equivalent	KEYTRUDA Biological, ONCOLOGY	A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in	2020
2020-12-29	BioMarin Pharmaceutical Inc.	$25,733	Research payment	Cash or cash equivalent		A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondrop	2020
2020-12-29	United Therapeutics Corporation	$12,331	Research payment	Cash or cash equivalent	TYVASO Drug, PAH	Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso	2020
2020-12-29	BioMarin Pharmaceutical Inc.	$9,373	Research payment	Cash or cash equivalent		A Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in	2020
2020-12-29	Eisai Inc.	$4,078	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$4,078	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$4,078	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$4,078	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$3,615	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$2,904	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	BioMarin Pharmaceutical Inc.	$2,360	Research payment	Cash or cash equivalent		Multicenter multinational study to collect consistent baseline growth measurements on pediatric patients with Achondropl	2020
2020-12-29	Terumo Medical Corporation	$2,100	Consulting Fee	Cash or cash equivalent	Navicross Device, Vascular Access		2020
2020-12-29	Terumo Medical Corporation	$2,100	Consulting Fee	Cash or cash equivalent	Navicross Device, Vascular Access		2020
2020-12-29	Eisai Inc.	$1,884	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,884	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,845	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,845	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,845	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,782	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	ABBVIE INC.	$1,560	Research payment	Cash or cash equivalent		M15-570	2020
2020-12-29	Eisai Inc.	$1,517	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,517	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Eisai Inc.	$1,517	Research payment	Cash or cash equivalent		A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Stud	2020
2020-12-29	Karyopharm Therapeutics Inc.	$1,040	Research payment	Cash or cash equivalent	XPOVIO Drug, Oncology	XPORT-COV-1001	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-29	Eisai Inc.	$799	Research payment	Cash or cash equivalent	Ontak Drug, Oncology	A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous	2020
2020-12-28	Regeneron Pharmaceuticals, Inc.	$50,937	Research payment	Cash or cash equivalent		A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies fo	2020
2020-12-28	Merck Sharp & Dohme LLC	$26,000	Research payment	In-kind items and services	KEYTRUDA Biological, ONCOLOGY	An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX 106 and INBRX-106 in Combination wit	2020
2020-12-28	Merck Sharp & Dohme LLC	$26,000	Research payment	In-kind items and services	KEYTRUDA Biological, ONCOLOGY	An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX 106 and INBRX-106 in Combination wit	2020
2020-12-28	Boehringer Ingelheim Pharmaceuticals, Inc.	$21,965	Research payment	Cash or cash equivalent		FIH Dose escalation ph1 DLL3 pos SCLC and other NE	2020
2020-12-28	Edwards Lifesciences Corporation	$2,600	Research payment	Cash or cash equivalent		Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System 2013-05C	2020
2020-12-28	Gen-Probe, Inc.	$1,248	Research payment	Cash or cash equivalent	Aptima Device, Diagnostics	P10934-CMVPS-CSP-01	2020
2020-12-28	Regeneron Pharmaceuticals, Inc.	$128	Research payment	Cash or cash equivalent		A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies fo	2020
2020-12-25	Amgen Inc.	$3,797	Research payment	Cash or cash equivalent		AMG 701 Ph1/2 Non-Randomized Open-Label Expansion MM	2020
2020-12-24	Intercept Pharmaceuticals, Inc.	$18,446	Research payment	Cash or cash equivalent	OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY	1011866	2020
2020-12-24	Intercept Pharmaceuticals, Inc.	$8,221	Research payment	Cash or cash equivalent	OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY	1011866	2020
2020-12-24	Intercept Pharmaceuticals, Inc.	$4,904	Research payment	Cash or cash equivalent		1009742	2020
2020-12-24	Janssen Research & Development, LLC	$3,613	Research payment	Cash or cash equivalent		Phase 2, Randomized, Open-Label Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus	2020
2020-12-24	Surmodics, Inc.	$1,570	Research payment	Cash or cash equivalent	SurVeil Device, Drug-Coated Balloon	TRANSCEND	2020
2020-12-24	Surmodics, Inc.	$1,570	Research payment	Cash or cash equivalent	SurVeil Device, Drug-Coated Balloon	TRANSCEND	2020
2020-12-24	Surmodics, Inc.	$1,570	Research payment	Cash or cash equivalent	SurVeil Device, Drug-Coated Balloon	TRANSCEND	2020
2020-12-24	Surmodics, Inc.	$1,570	Research payment	Cash or cash equivalent	SurVeil Device, Drug-Coated Balloon	TRANSCEND	2020

The latest 200 records of 3,830.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Atlanta, GA, county Fulton County, GA, state Georgia; placed by its city name.

Measure	Place (city or town) Atlanta, GA	County Fulton County, GA	State Georgia
Population B01003	505,268	1,076,561	10,940,407
Population, 2020 census P1	498,715	1,066,710	10,711,908
Median age B01002	34.2	36.4	37.6
Under 18 B01001	16.6%	20.9%	23.2%
65 and over B01001	12.3%	12.7%	15.0%
Households B11001	236,468	462,481	4,074,366
Foreign born B05002	9.0%	14.1%	11.2%
Median household income B19013	$85,652	$95,292	$77,353
Median family income B19113	$118,333	$130,000	$93,754
Per capita income B19301	$65,718	$63,269	$40,924
Poverty rate B17001	16.9%	12.3%	13.4%
Unemployment rate B23025	5.9%	5.4%	5.1%
Civilian labor force B23025	295,134	609,750	5,496,061
Mean commute (minutes) B08013	26.5	27.7	28.3
Bachelor's degree or higher B15003	59.2%	58.5%	34.9%
Housing units B25001	265,899	507,119	4,541,835
Owner-occupied B25003	46.4%	54.3%	65.7%
Renters B25003	53.6%	45.7%	34.3%
Median home value B25077	$439,600	$458,800	$303,300
Median gross rent B25064	$1,711	$1,732	$1,393
White, not Hispanic B03002	38.1%	36.8%	49.1%
Black B03002	45.4%	42.1%	30.7%
Hispanic or Latino B03002	6.3%	8.2%	11.0%
Asian B03002	5.2%	7.8%	4.5%
American Indian and Alaska Native B03002	0.1%	0.1%	0.1%

Economy now FRED unemployment 3.3% in Sep 2026 (3.4% a year earlier); per capita personal income $65,111 in 2025, up 26% in five years (+1.6% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Atlanta, GA.